Entrada Therapeutics, Inc. (TRDA) Tops Q1 EPS by 31c

Entrada Therapeutics, Inc. (NASDAQ: TRDA) reported Q1 EPS of ($0.42), $0.31 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Entrada Therapeutics, Inc. (TRDA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Flash Sports posts $266M in assets after merger, net loss widens
• Lakeland Industries qualifies Vietnam cleanroom for critical environment output